ORLOFF JOHN J 4
4 · ALEXION PHARMACEUTICALS, INC. · Filed Jun 9, 2020
Insider Transaction Report
Form 4
ORLOFF JOHN J
EVP, Research & Development
Transactions
- Tax Payment
Common Stock, par value $.0001 per share
2020-06-08$114.61/sh−2,784$319,074→ 44,529 total
Footnotes (1)
- [F1]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.